Ferring Pharmaceuticals today announced it has advanced three studies in the ADSTILADRIN® (nadofaragene firadenovec-vncg) clinical trial program ? two studies in patients with non-muscle invasive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback